Clinical Trial Update: Effect of Metadoxine on Oxidative Stress in Non-alcoholic Hepatic Steatosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating metadoxine for reducing oxidative stress in non-alcoholic fatty liver disease in patients with prediabetes. The current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Prediabetes

Drugs mentioned

• Metadoxine (metadoxine)

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: NAFLD, Pre-diabetes | Phase 4 | Status: UNKNOWN